TACE Plus Sorafenib Versus TACE Alone for Recurrent Intermediate Hepatocellular Carcinoma
Clinical trial NCT04103398 · COMPLETED
Trial details
- NCT number
- NCT04103398
- Sponsor
- Sun Yat-sen University
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2019-10-02
- Primary completion
- 2023-12-31
- Enrollment
- 162
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.